• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

模拟微重力下 3-羟基丁酸及其衍生物抗骨质疏松作用的机制。

The mechanism of anti-osteoporosis effects of 3-hydroxybutyrate and derivatives under simulated microgravity.

机构信息

MOE Key Lab of Bioinformatics, Department of Biological Science and Biotechnology, School of Life Sciences, Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing 100084, China.

State Key Laboratory of Automotive Safety and Energy, Tsinghua University, Beijing 100084, China.

出版信息

Biomaterials. 2014 Sep;35(28):8273-83. doi: 10.1016/j.biomaterials.2014.06.020. Epub 2014 Jun 26.

DOI:10.1016/j.biomaterials.2014.06.020
PMID:24976243
Abstract

Skeletons have significant bone loss (osteoporosis) under microgravity environment. This study showed that microbial polyhydroxyalkanoates (PHA) degradation product, and also ketone body 3-hydroxybutyrate acid (3HB) and its derivative 3-hydroxybutyrate methyl ester (3HBME) inhibit the development of osteoporosis in mice maintained under simulated microgravity, helping preserve bone microstructure and mechanical property. Mice orally administrated with 3HB or 3HBME recovered much more quickly from osteoporosis resulted from simulated microgravity compared with the controls without 3HB or 3HBME treatments due to less calcium loss to the sera. It was known that abnormal activation of osteoclasts induced by microgravity led to bone tissue absorption and thus osteoporosis. In this study, it was found that 3HB or 3HBME down-regulated the nuclear factor of activated T-cells cytoplasmic 1 (NFATc1), which is the transcription factor of pre-osteoclast differentiation. When NFATc1 activation and downstream functions were inhibited, 3HB or 3HBME was able to strongly reduce pre-osteoclast differentiation. As a result, bone absorption was prevented. It was demonstrated that 100 mg/kg 3HB resulted in the most obvious effect on osteoporosis prevention. Based on these results, 3HB and 3HBME should be further developed as novel drug candidates against osteoporosis induced by microgravity.

摘要

在微重力环境下,骨骼会出现明显的骨质流失(骨质疏松症)。本研究表明,微生物聚羟基脂肪酸酯(PHA)降解产物,以及酮体 3-羟基丁酸(3HB)及其衍生物 3-羟基丁酸甲酯(3HBME),可抑制模拟微重力环境下维持的小鼠骨质疏松症的发展,有助于保持骨微观结构和机械性能。与未用 3HB 或 3HBME 治疗的对照组相比,经口给予 3HB 或 3HBME 的小鼠从模拟微重力引起的骨质疏松症中恢复得更快,因为血清中钙的流失较少。众所周知,微重力引起的破骨细胞异常激活导致骨组织吸收,从而导致骨质疏松症。在这项研究中,发现 3HB 或 3HBME 下调核因子活化 T 细胞细胞质 1(NFATc1),NFATc1 是破骨前细胞分化的转录因子。当 NFATc1 的激活和下游功能受到抑制时,3HB 或 3HBME 能够强烈抑制破骨前细胞的分化。因此,防止了骨吸收。结果表明,100mg/kg 的 3HB 对预防骨质疏松症的效果最为明显。基于这些结果,3HB 和 3HBME 应进一步开发为针对微重力引起的骨质疏松症的新型药物候选物。

相似文献

1
The mechanism of anti-osteoporosis effects of 3-hydroxybutyrate and derivatives under simulated microgravity.模拟微重力下 3-羟基丁酸及其衍生物抗骨质疏松作用的机制。
Biomaterials. 2014 Sep;35(28):8273-83. doi: 10.1016/j.biomaterials.2014.06.020. Epub 2014 Jun 26.
2
Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.曲匹地尔,一种血小板衍生生长因子拮抗剂,通过下调 NFATc1 抑制破骨细胞生成,并抑制小鼠的骨丢失。
Biochem Pharmacol. 2013 Sep 15;86(6):782-90. doi: 10.1016/j.bcp.2013.07.015. Epub 2013 Aug 6.
3
Modeled microgravity stimulates osteoclastogenesis and bone resorption by increasing osteoblast RANKL/OPG ratio.模拟微重力通过增加成骨细胞RANKL/OPG比值刺激破骨细胞生成和骨吸收。
J Cell Biochem. 2007 Feb 1;100(2):464-73. doi: 10.1002/jcb.21059.
4
Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.咖啡酸 3,4-二羟基苯乙基酯通过抑制丝裂原活化蛋白激酶/激活蛋白 1 和 Ca2+-活化 T 细胞胞浆 1 信号通路抑制核因子 κB 配体诱导的破骨细胞生成,预防卵巢切除诱导的骨丢失。
J Bone Miner Res. 2012 Jun;27(6):1298-1308. doi: 10.1002/jbmr.1576.
5
Effects of microgravity on osteoclast bone resorption and osteoblast cytoskeletal organization and adhesion.微重力对破骨细胞骨吸收和成骨细胞细胞骨架组织和黏附的影响。
Bone. 2011 Nov;49(5):965-74. doi: 10.1016/j.bone.2011.07.036. Epub 2011 Aug 2.
6
Harmine, a β-carboline alkaloid, inhibits osteoclast differentiation and bone resorption in vitro and in vivo.哈尔明,一种β-咔啉生物碱,在体外和体内抑制破骨细胞分化和骨吸收。
Eur J Pharmacol. 2011 Jan 15;650(2-3):511-8. doi: 10.1016/j.ejphar.2010.10.048. Epub 2010 Nov 1.
7
Oleanolic acid acetate inhibits osteoclast differentiation by downregulating PLCγ2-Ca(2+)-NFATc1 signaling, and suppresses bone loss in mice.醋酸齐墩果酸通过下调 PLCγ2-Ca(2+)-NFATc1 信号通路抑制破骨细胞分化,并抑制小鼠的骨丢失。
Bone. 2014 Mar;60:104-11. doi: 10.1016/j.bone.2013.12.013. Epub 2013 Dec 17.
8
Inhibition of osteoclast differentiation and bone resorption by rotenone, through down-regulation of RANKL-induced c-Fos and NFATc1 expression.鱼藤酮通过下调 RANKL 诱导的 c-Fos 和 NFATc1 表达抑制破骨细胞分化和骨吸收。
Bone. 2010 Mar;46(3):724-31. doi: 10.1016/j.bone.2009.10.042. Epub 2009 Nov 6.
9
Aminocoumarins inhibit osteoclast differentiation and bone resorption via downregulation of nuclear factor of activated T cells c1.氨基酮戊酸类药物通过下调激活 T 细胞核因子 c1 抑制破骨细胞分化和骨吸收。
Biochem Pharmacol. 2013 Feb 1;85(3):417-25. doi: 10.1016/j.bcp.2012.10.022. Epub 2012 Nov 1.
10
Inhibitory effects of Stewartia koreana on osteoclast differentiation and bone resorption.韩国紫茎对破骨细胞分化和骨吸收的抑制作用。
Int Immunopharmacol. 2007 Dec 5;7(12):1507-16. doi: 10.1016/j.intimp.2007.07.016. Epub 2007 Aug 8.

引用本文的文献

1
Molecular Mechanism of Microgravity-Induced Intestinal Flora Dysbiosis on the Abnormalities of Liver and Brain Metabolism.微重力诱导的肠道菌群失调对肝脏和大脑代谢异常的分子机制
Int J Mol Sci. 2025 Mar 27;26(7):3094. doi: 10.3390/ijms26073094.
2
Ketogenic diets and β-hydroxybutyrate in the prevention and treatment of diabetic kidney disease: current progress and future perspectives.生酮饮食和β-羟基丁酸酯在糖尿病肾病防治中的研究进展与展望
BMC Nephrol. 2025 Mar 7;26(1):127. doi: 10.1186/s12882-025-04019-0.
3
Ketogenic diet and β-hydroxybutyrate in osteoporosis: current progress and controversy.
生酮饮食与β-羟基丁酸在骨质疏松症中的研究:当前进展与争议
Front Nutr. 2025 Jan 23;12:1508695. doi: 10.3389/fnut.2025.1508695. eCollection 2025.
4
Gut microbiota and microbial metabolites for osteoporosis.用于骨质疏松症的肠道微生物群和微生物代谢产物
Gut Microbes. 2025 Dec;17(1):2437247. doi: 10.1080/19490976.2024.2437247. Epub 2024 Dec 17.
5
Integration of Proteomic and Metabolomic Data Reveals the Lipid Metabolism Disorder in the Liver of Rats Exposed to Simulated Microgravity.蛋白质组学和代谢组学数据的整合揭示了模拟微重力暴露大鼠肝脏中的脂质代谢紊乱。
Biomolecules. 2024 Jun 12;14(6):682. doi: 10.3390/biom14060682.
6
CircZfp644-205 inhibits osteoblast differentiation and induces apoptosis of pre-osteoblasts via sponging miR-455-3p and promoting SMAD2 expression.环状 RNA Zfp644-205 通过海绵吸附 miR-455-3p 和促进 SMAD2 表达抑制成骨细胞分化并诱导前成骨细胞凋亡。
Eur J Med Res. 2024 Jun 8;29(1):315. doi: 10.1186/s40001-024-01903-7.
7
Supplementing Low-Sodium Bicarbonate-Calcic (Lete) Water: Effects in Women on Bone and Systemic Metabolism.补充低钠碳酸氢钙(莱特)水:对女性骨骼和全身代谢的影响。
Metabolites. 2023 Oct 24;13(11):1109. doi: 10.3390/metabo13111109.
8
β-Hydroxybutyrate as an epigenetic modifier: Underlying mechanisms and implications.β-羟基丁酸作为一种表观遗传修饰剂:潜在机制及影响
Heliyon. 2023 Oct 17;9(11):e21098. doi: 10.1016/j.heliyon.2023.e21098. eCollection 2023 Nov.
9
Metabolomics analysis of the potential mechanism of Yi-Guan-Jian decoction to reverse bone loss in glucocorticoid-induced osteoporosis.基于代谢组学分析探讨一贯煎对糖皮质激素性骨质疏松症骨丢失的作用机制。
J Orthop Surg Res. 2023 Jun 5;18(1):409. doi: 10.1186/s13018-023-03778-6.
10
Recent trends of biotechnological production of polyhydroxyalkanoates from C1 carbon sources.利用C1碳源通过生物技术生产聚羟基脂肪酸酯的最新趋势。
Front Bioeng Biotechnol. 2023 Jan 6;10:907500. doi: 10.3389/fbioe.2022.907500. eCollection 2022.